Hiv dna integration

R Craigie, FD Bushman - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
Retroviruses are distinguished from other viruses by two characteristic steps in the viral
replication cycle. The first is reverse transcription, which results in the production of a double …

Nuclear landscape of HIV-1 infection and integration

M Lusic, RF Siliciano - Nature Reviews Microbiology, 2017 - nature.com
To complete its life cycle, HIV-1 enters the nucleus of the host cell as reverse-transcribed
viral DNA. The nucleus is a complex environment, in which chromatin is organized to …

[HTML][HTML] Rapid manufacturing of non-activated potent CAR T cells

S Ghassemi, JS Durgin, S Nunez-Cruz… - Nature biomedical …, 2022 - nature.com
Chimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell
haematologic malignancies. The manufacturing of these T cells typically involves their …

[HTML][HTML] HIV-1 integration landscape during latent and active infection

LB Cohn, IT Silva, TY Oliveira, RA Rosales, EH Parrish… - Cell, 2015 - cell.com
The barrier to curing HIV-1 is thought to reside primarily in CD4+ T cells containing silent
proviruses. To characterize these latently infected cells, we studied the integration profile of …

Nuclear architecture dictates HIV-1 integration site selection

B Marini, A Kertesz-Farkas, H Ali, B Lucic, K Lisek… - Nature, 2015 - nature.com
Long-standing evidence indicates that human immunodeficiency virus type 1 (HIV-1)
preferentially integrates into a subset of transcriptionally active genes of the host cell …

[HTML][HTML] HIV latency is established directly and early in both resting and activated primary CD4 T cells

L Chavez, V Calvanese, E Verdin - PLoS pathogens, 2015 - journals.plos.org
Highly active antiretroviral therapy (HAART) suppresses human immunodeficiency virus
(HIV) replication to undetectable levels but cannot fully eradicate the virus because a small …

Understanding HIV latency: the road to an HIV cure

MS Dahabieh, E Battivelli, E Verdin - Annual review of medicine, 2015 - annualreviews.org
Treatment with antiretroviral therapy dramatically increases the survival of HIV-infected
individuals. However, treatment has to be continued for life because it does not lead to the …

The molecular basis for human immunodeficiency virus latency

U Mbonye, J Karn - Annual review of virology, 2017 - annualreviews.org
Although potent combination antiretroviral therapy can effectively block viral replication in
the host, human immunodeficiency virus (HIV) persists due to the existence of latent but …

[HTML][HTML] A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers

DP Wong, NK Roy, K Zhang, A Anukanth… - Nature …, 2022 - nature.com
B cell-activating factor (BAFF) binds the three receptors BAFF-R, BCMA, and TACI,
predominantly expressed on mature B cells. Almost all B cell cancers are reported to …

[HTML][HTML] Spatially clustered loci with multiple enhancers are frequent targets of HIV-1 integration

B Lucic, HC Chen, M Kuzman, E Zorita… - Nature …, 2019 - nature.com
HIV-1 recurrently targets active genes and integrates in the proximity of the nuclear pore
compartment in CD4+ T cells. However, the genomic features of these genes and the …